CIBC Private Wealth Group’s ESSA Pharma EPIX Stock Holding History

CIBC Private Wealth Group’s Portfolio EPIX Stock Details EPIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,500	Closed	-$478	–	3436
2025 Q3	$478	Hold	2,500	–	–	﹤0.01%	2889
2025 Q2	$4.25K	Hold	2,500	–	–	﹤0.01%	2486
2025 Q1	$3.67K	Hold	2,500	–	–	﹤0.01%	2536
2024 Q4	$4.55K	Hold	2,500	–	–	﹤0.01%	2495
2024 Q3	$15.2K	Hold	2,500	–	–	﹤0.01%	2270
2024 Q2	$12.9K	Hold	2,500	–	–	﹤0.01%	2200
2024 Q1	$21.1K	Buy	+2,500	New	+$21.8K	﹤0.01%	2023

CIBC Private Wealth Group's EPIX Position: Q4 2025 in Review

CIBC Private Wealth Group sold out of ESSA Pharma (EPIX) in Q4 2025, closing a stake of 2,500 shares — an estimated $478 sold.

CIBC Private Wealth Group first reported a position in EPIX in Q1 2024 and held it in 7 quarters. The position peaked at $21.1K in Q1 2024. 0 funds tracked by Wall St. Rank hold EPIX as of Q4 2025.

CIBC Private Wealth Group reported no remaining ESSA Pharma position as of Q4 2025 after selling out during the quarter.
CIBC Private Wealth Group sold 2,500 ESSA Pharma shares in Q4 2025, an estimated $478.
CIBC Private Wealth Group first reported a position in ESSA Pharma in Q1 2024 and held it in 7 quarters.
CIBC Private Wealth Group's ESSA Pharma position peaked at $21.1K in Q1 2024.
0 funds tracked by Wall St. Rank held ESSA Pharma as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.